Logo image
Diagnostic Performance of PET and Perfusion-Weighted malting in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature
Journal article   Open access   Peer reviewed

Diagnostic Performance of PET and Perfusion-Weighted malting in Differentiating Tumor Recurrence or Progression from Radiation Necrosis in Posttreatment Gliomas: A Review of Literature

N. Soni, M. Ora, N. Mohindra, Y. Menda and G. Bathla
American journal of neuroradiology : AJNR, Vol.41(9), pp.1550-1557
09/01/2020
DOI: 10.3174/ajnr.A6685
PMCID: PMC7583093
PMID: 32855194
url
https://doi.org/10.3174/ajnr.A6685View
Published (Version of record) Open Access

Abstract

Tumor resection followed by chemoradiation remains the current criterion standard treatment for high-grade gliomas. Regardless of aggressive treatment, tumor recurrence and radiation necrosis are 2 different outcomes. Differentiation of tumor recurrence from radiation necrosis remains a critical problem in these patients because of considerable overlap in clinical and imaging presentations. Contrast-enhanced MR imaging is the universal imaging technique for diagnosis, treatment evaluation, and detection of recurrence of high-grade gliomas. PWI and PET with novel radiotracers have an evolving role for monitoring treatment response in high-grade gliomas. In the literature, there is no clear consensus on the superiority of either technique or their complementary information. This review aims to elucidate the diagnostic performance of individual and combined use of functional (PWI) and metabolic (PET) imaging modalities to distinguish recurrence from posttreatment changes in gliomas.
Clinical Neurology Life Sciences & Biomedicine Neuroimaging Neurosciences & Neurology Radiology, Nuclear Medicine & Medical Imaging Science & Technology

Details

Metrics

Logo image